1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
4 Premium Insights
4.1 Precision Medicine Software: Market Overview
4.2 Geographic Analysis: North American Precision Medicine Software Market, By Delivery Mode
4.3 Us Precision Medicine Software Market
4.4 Geographical Snapshot of the Precision Medicine Software Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Government Funding in Precision Medicine Initiatives
5.2.1.2 Partnerships Among Pharmaceutical and Software Companies
5.2.1.3 Entry of New Players and Vc Funding
5.2.1.4 Growth in the Number of Cancer Patients
5.2.2 Restraints
5.2.2.1 High Cost of Deployment
5.2.3 Opportunities
5.2.3.1 Emerging Countries
5.2.3.2 Cloud-Based Solutions
5.2.3.3 Artificial Intelligence in Precision Medicine
5.2.4 Challenges
5.2.4.1 Secure Storage of Large Volumes of Sequenced Data
5.2.4.2 Lack of Reimbursement for Precision Medicine-Based Treatments
5.2.4.3 Lack of Skilled It Professionals in Healthcare
6 Precision Medicine Software Market, By Delivery Mode
6.1 Introduction
6.2 On-Premise Delivery Mode
6.2.1 Benefits Offered By the On-Premise Delivery Model and Limited Penetration of Cloud-Based Technologies to Drive Market Growth
6.3 Cloud-Based Delivery Mode
6.3.1 Open-Access Nature of Cloud-Based Models Poses Security Challenges
7 Precision Medicine Software Market, By End User
7.1 Introduction
7.2 Healthcare Providers
7.2.1 Precision Medicine is Used By Healthcare Providers to Determine Disease Susceptibility and Provide Personalized Treatments
7.3 Research Centers and Government Institutes
7.3.1 Increasing Funding for Research Will Drive the Usage and Adoption of Precision Medicine Software in This Segment
7.4 Pharmaceutical & Biotechnology Companies
7.4.1 Increasing Emphasis on Pharmacogenomics Due to Its Applications in Drug Development is to Drive Market Growth
7.5 Other End Users
8 Precision Medicine Software Market, By Application
8.1 Introduction
8.2 Oncology
8.2.1 Oncology Segment to Witness the Highest Growth in the Precision Medicine Software Market
8.3 Pharmacogenomics
8.3.1 Pharmacogenomics is A Potential Solution to Reduce Healthcare Costs Associated With Ades and Poor Response to Pharmacotherapy
8.4 Rare Diseases
8.4.1 Increasing Incidence of Rare Diseases to Drive Market Growth
8.5 Other Applications
9 Precision Medicine Software Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Government Funding to Support Market Growth in the US
9.2.2 Canada
9.2.2.1 Rising Incidence of Cancer in Canada Will Drive the Demand for Precision Medicine Software
9.3 Europe
9.3.1 Eu5
9.3.1.1 Favorable Funding Scenario Will Support Market Growth in Eu5
9.3.2 Rest of Europe
9.4 Asia
9.4.1 Growing Research Investments in China, Japan & India Will Contribute to Market Growth in Asia
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
10.2 Market Ranking of Players, 2018
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Scenario
10.4.1 Solution Launches
10.4.2 Expansions
10.4.3 Partnerships, Agreements, and Collaborations
10.4.4 Acquisitions
11 Company Profiles
11.1 Syapse, Inc.
11.2 2bprecise, LLC
11.3 Fabric Genomics, Inc.
11.4 Foundation Medicine, Inc.
11.5 Sophia Genetics Sa
11.6 Pieriandx, Inc.
11.7 N-Of-One, Inc. (A Subsidiary of Qiagen N.V.)
11.8 Human Longevity, Inc.
11.9 Translational Software Inc.
11.10 Sunquest Information Systems, Inc.
11.11 Gene42, Inc.
11.12 Lifeomic Health, LLC
12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
List of Tables
Table 1 Government Initiatives in the Field of Precision Medicine Software
Table 2 Start-Up Companies in the Precision Medicine Software Market
Table 3 Market, By Delivery Mode, 2017–2024 (USD Million)
Table 4 On-Premise Precision Medicine Software Market, By Region, 2017–2024 (USD Million)
Table 5 North America: On-Premise Precision Medicine Software Market, By Country, 2017–2024 (USD Million)
Table 6 Europe: On-Premise Precision Medicine Software Market, By Region, 2017–2024 (USD Million)
Table 7 Cloud-Based Precision Medicine Software Market, By Region, 2017–2024 (USD Million)
Table 8 North America: Cloud-Based Precision Medicine Software Market, By Country, 2017–2024 (USD Million)
Table 9 Europe: Cloud-Based Precision Medicine Software Market, By Region, 2017–2024 (USD Million)
Table 10 Market, By End User, 2017–2024 (USD Million)
Table 11 Market for Healthcare Providers, By Region, 2017–2024 (USD Million)
Table 12 North America: Market for Healthcare Providers, By Country, 2017–2024 (USD Million)
Table 13 Europe: Market for Healthcare Providers, By Country, 2017–2024 (USD Million)
Table 14 Market for Research Centers and Government Institutes, By Region, 2017–2024 (USD Million)
Table 15 North America: Market for Research Centers and Government Institutes, By Country, 2017–2024 (USD Million)
Table 16 Europe: Market for Research Centers and Government Institutes, By Country, 2017–2024 (USD Million)
Table 17 Market for Pharmaceutical and Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 18 North America: Market for Pharmaceutical and Biotechnology Companies, By Country, 2017–2024 (USD Million)
Table 19 Europe: Market for Pharmaceutical and Biotechnology Companies, By Country, 2017–2024 (USD Million)
Table 20 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 21 North America: Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 22 Europe: Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 23 Market, By Application, 2017–2024 (USD Million)
Table 24 Market for Oncology, By Region, 2017–2024 (USD Million)
Table 25 North America: Market for Oncology, By Country, 2017–2024 (USD Million)
Table 26 Europe: Market for Oncology, By Region, 2017–2024 (USD Million)
Table 27 Market for Pharmacogenomics, By Region, 2017–2024 (USD Million)
Table 28 North America: Market for Pharmacogenomics, By Country, 2017–2024 (USD Million)
Table 29 Europe: Market for Pharmacogenomics, By Region, 2017–2024 (USD Million)
Table 30 Market for Rare Diseases, By Region, 2017–2024 (USD Million)
Table 31 North America: Market for Rare Diseases, By Country, 2017–2024 (USD Million)
Table 32 Europe: Market for Rare Diseases, By Region, 2017–2024 (USD Million)
Table 33 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 34 North America: Market for Other Applications, By Country, 2017–2024 (USD Million)
Table 35 Europe: Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 36 Market, By Region, 2017–2024 (USD Million)
Table 37 North America: Market, By Country, 2017–2024 (USD Million)
Table 38 North America: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 39 North America: Market, By End User, 2017–2024 (USD Million)
Table 40 North America: Market, By Application, 2017–2024 (USD Million)
Table 41 US: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 42 US: Market, By End User, 2017–2024 (USD Million)
Table 43 US: Market, By Application, 2017–2024 (USD Million)
Table 44 Canada: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 45 Canada: Market, By End User, 2017–2024 (USD Million)
Table 46 Canada: Market, By Application, 2017–2024 (USD Million)
Table 47 Europe: Market, By Region, 2017–2024 (USD Million)
Table 48 Europe: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 49 Europe: Market, By End User, 2017–2024 (USD Million)
Table 50 Europe: Market, By Application, 2017–2024 (USD Million)
Table 51 Eu5: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 52 Eu5: Market, By End User, 2017–2024 (USD Million)
Table 53 Eu5: Market, By Application, 2017–2024 (USD Million)
Table 54 ROE: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 55 ROE: Market, By End User, 2017–2024 (USD Million)
Table 56 ROE: Market, By Application, 2017–2024 (USD Million)
Table 57 Asia: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 58 Asia: Market, By End User, 2017–2024 (USD Million)
Table 59 Asia: Market, By Application, 2017–2024 (USD Million)
Table 60 RoW: Market, By Delivery Mode, 2017–2024 (USD Million)
Table 61 RoW: Market, By End User, 2017–2024 (USD Million)
Table 62 RoW: Market, By Application, 2017–2024 (USD Million)
Table 63 Solution Launches
Table 64 Expansions
Table 65 Partnerships, Agreements, and Collaborations
Table 66 Acquisitions
List of Figures
Figure 1 Research Methodology: Precision Medicine Software
Figure 2 Research Design
Figure 3 Sampling Frame: Primary Research
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market Share, By Delivery Mode, 2018
Figure 8 Market Share, By End User, 2018
Figure 9 Market Share, By Application, 2018
Figure 10 Geographic Snapshot of the Precision Medicine Software Market
Figure 11 Rising Government Funding in Precision Medicine Initiatives to Drive Market Growth During the Forecast Period
Figure 12 On-Premise Delivery Mode Accounted for the Largest Share of the North American Precision Medicine Software Market in 2018
Figure 13 Healthcare Providers Accounted for the Largest Market Share in 2018
Figure 14 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Market, By Region, 2019 vs. 2024 (USD Million)
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia: Market Snapshot
Figure 20 RoW: Market Snapshot
Figure 21 Key Developments in the Precision Medicine Software Market Between 2016 and 2019
Figure 22 Market Ranking, By Key Player (2018)
Figure 23 Market (Global), Competitive Leadership Mapping, 2018